COSMOS Pharmaceutical (3349) · FactDropped
Inventory valuation write-down caused by leaving tax-inclusive prices unchanged at the time of a consumption tax hike
First written in FY2020-Q2. 1 of 2 entries say "Dropped", first in FY2021. Latest entry: FY2021.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Inventory valuation write-down caused by leaving tax-inclusive prices unchanged at the time of a consumption tax hikeA theme 1 companies write about · 1 as a headwind · 0 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2021DroppedAnnual reportThe explanation of operating results for the fiscal year contains no explicit reference to an inventory valuation write-down caused by leaving tax-inclusive prices unchanged when the consumption tax was raised.
- FY2020-Q2First statedAnnual report
「In addition, holding tax-inclusive prices unchanged when the tax was increased resulted in a write-down of inventory.」
The company states that maintaining tax-inclusive prices during the consumption tax increase resulted in an inventory write-down.